Abstract
Percutaneous cryoablation is an evolving method of definitive renal mass treatment. With growing experience showing durability of treatment, cryoablation is a reasonable treatment option for an expanding patient population. In addition, large tumors may be treated using multiple cryoprobes. Patients may be treated under IV sedation, although general anesthesia may be more appropriate, particularly for larger tumors or technically complicated cases. Follow-up imaging is typically performed several times in the first 12 months following ablation and then every 6–12 months thereafter, depending on the tumor biology and other clinical indications. Outcomes following ablation have shown short- and midterm local control rates of about 95 %. Major complications are rare, occurring in about 5–7 % of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Uchida M, et al. Percutaneous cryosurgery for renal tumours. Br J Urol. 1995;75(2):132–6. discussion 136–7.
Magrill D, et al. Laparoscopy extirpative renal surgery in the octogenarian population. J Endourol. 2009;23(9):1499–502.
Atwell TD, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179(6):2136–40. discussion 2140–1.
Gupta A, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175(2):447–52. discussion 452–3.
Littrup PJ, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18(3):383–92.
Silverman SG, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy–initial experience in 23 patients. Radiology. 2005;236(2):716–24.
Johnson A, et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol. 2008;180(1):89–93. discussion 93.
Atwell TD, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188(5):1195–200.
Littrup PJ, et al. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol. 2009;20(10):1343–51.
Bagley DH, et al. Cryosurgery of the ureter in dogs. Invest Urol. 1976;14(3):241–5.
Atwell TD, et al. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 2006;17(3):573–5.
Bodily KD, et al. Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol. 2010;194(3):779–83.
Froemming A, et al. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010;21(1):148–51.
Tuncali K, et al. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur J Radiol. 2006;59(2):198–202.
Wah TM, et al. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.
Gervais DA, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):64–71.
Varkarakis IM, et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol. 2005;174(2):456–60. discussion 460.
Warlick CA, et al. Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology. 2006;67(5):918–22.
Dechet CB, et al. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999;162(4):1282–4. discussion 1284–5.
Dechet CB, et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol. 2003;169(1):71–4.
Wunderlich H, et al. The accuracy of 250 fine needle biopsies of renal tumors. J Urol. 2005;174(1):44–6.
Heilbrun ME, et al. CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR Am J Roentgenol. 2007;188(6):1500–5.
Frank I, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.
Thompson RH, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181(5):2033–6.
Silverman SG, et al. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240(1):6–22.
Beland MD, et al. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am J Roentgenol. 2007;188(3):792–7.
Woodrum DA, et al. Role of intraarterial embolization before cryoablation of large renal tumors: a pilot study. J Vasc Interv Radiol. 2010;21(6):930–6.
Allaf ME, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology. 2005;237(1):366–70.
Gupta A, et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol. 2009;23(7):1099–105.
Woolley ML, et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16(7):519–22.
Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.
Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166(4):853–5.
Chosy SG, et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159(4):1370–4.
Campbell SC, et al. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):29–33. discussion 33–4.
Goldberg SN, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–39.
Goldberg SN, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228(2):335–45.
Matin SF, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7.
Campbell SC, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.
Chin AI, et al. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006;8(1):1–7.
Porter CA, et al. MRI after technically successful renal cryoablation: early contrast enhancement as a common finding. AJR Am J Roentgenol. 2010;194(3):790–3.
Shingleton WB, Sewell Jr PE. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol. 2001;165(3):773–6.
Bandi G, et al. Cryoablation of small renal masses: assessment of the outcome at one institution. BJU Int. 2007;100(4):798–801.
Rodriguez R, et al. Prospective analysis of the safetyand efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Intervent Radiol. 2011;34(3):573–8.
Atwell TD, et al. Percutaneous renal cryoablation: Local control at mean 26 months of followup. J Urol. 2010;184(4):1291–5.
Schmit GD, et al. Percutaneous cryoablation of renal masses > or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol. 2010;24(8):1255–62.
Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68(1 Suppl):2–6.
Gill IS, et al. Renal cryoablation: outcome at 3 years. J Urol. 2005;173(6):1903–7.
Sutor AH, Bowie EJ, Owen Jr CA. Effect of temperature on hemostasis: a cold-tolerance test. Blut. 1971;22(1):27–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Atwell, T.D., Callstrom, M. (2013). Percutaneous Renal Cryoablation. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_49
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0751-6_49
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0750-9
Online ISBN: 978-1-4419-0751-6
eBook Packages: MedicineReference Module Medicine